Estrogens in Maternal Plasma Following Intraamniotic Injection of 4(1976)255 (3H)-Dehydroepiandrosterone-Sulfate in Midpregnancy

Total Page:16

File Type:pdf, Size:1020Kb

Estrogens in Maternal Plasma Following Intraamniotic Injection of 4(1976)255 (3H)-Dehydroepiandrosterone-Sulfate in Midpregnancy Lehmann et al., Intraamniotic injection of DHEA-S in mid-pregnancy 255 J. Perinat. Med. Estrogens in maternal plasma following intraamniotic injection of 4(1976)255 (3H)-dehydroepiandrosterone-sulfate in midpregnancy W. D. Lehmann*, J. R. Strecker Department of Gynecology and Obstetrics University of Ulm, Germany This investigation was initiated to study the test was performed by precursor application to the kinetics of C19 and C18 steroids in maternal plasma maternal compartment i.e. by intravenous injection following application of 3H-labelled estrogen· of DHEA-S into the maternal cubital vein. Since precursors to the fetal compartment. It was hoped the amniotic fluid has become more easily acces- to obtain Information about the quantity and sible due to better techniques the possibility of a quality of the fetoplacental steroid-metabolism in new placenta function test using intraamniotic the direction of fetus to mother. DHEA-S injection was examined simultaneously. In the past years LAU RITZEN and coworkers [5,6, In the following investigations of 4 normal preg- 7] have developed a placental function test in nancies between the 18th to 20th week of ges- which dehydroepiandrosterone-sulfate s an estro- tation, we applied (3H)-labelled dehydroepi- gen-precursor was injected into the mother. There- androsterone-sulfate directly into the fetal com- after the increase of the estrogen-excretion in the partment i.e. intraamniotical. Subsequently these 24-h-urine or the estrogen level in maternal plasma pregnancies were legally terminated by injection of was determined s a parameter of placental meta- prostaglandine after the test-procedure. bolic activity [20]. Both urinary and plasma es- trogens rose markedly after application of the androgenic steroidprecursor s confirmed by l Materials and methods investigators[2, 21,19]. After locating the placenta by ultrasonic Vision in The DHEA-S induced increase in urinary or plasma 4 patients, ΙΟΟμΟί DHEA-7a-3H-sulfate (spez. estrogens provides Information about the reserve- activity 1000 mCi/mmol) + 5 mg DHEA in sterile capacity of the placenta. Using incubation studies 0.9% NaCl were injected transabdominally into with placental tissue we could demonstrate in the amniotic cavity. Ten milliliters of blood was vitro that the conversion of DHEA to estrogens by drawn from the cubital vein of the pregnant the placental aromatising enzyme-system is signif- women before injection and after 15, 30, 60,120, icantly reduced in pathological pregnancies (pre- 180 und 240 niinutes into heparinized tubes. After eclampsia, diabetes, postmaturity) s compared to centrifugation 5 ml of plasma was incubated with normal pregnancies [10, 12, 13]. These studies 5000 IU 0-glucuronidase sulfatase (BOEHRINGER) demonstrated that in complicated pregnancies the for 2 hrs. at pH 5.4 and 37°C in a shaking thermo- diminished capacity of the aromatizing enzyme- stat. Extraction of the total free metabolites was system can occur and may result in a reduced processed three times with ether/chloroform. estrogen production which is of great clinical importance. Untilnowthe dehydroepiandrosterone- * With support of DFG SFB 87, project C5. J. Perinat. Med. 4(1976) 256 Lehmann et al., Intraamniotic injection of DHEA-S in mid-pregnancy The extracts were evaporated to dryness and the From the C19-steroid-fr?ction, 16a-hydroxy- dry residues were redissolved in warm methanol DHEA was isolated with highest concentration in and pipetted into formamid-saturated paper for plasma. The recovery of unchanged (3H)-DHEA-S, chromatography. Separation of C18 and C19- the steroid that had been initially injected, was steroids was performed in formamid/monochlor- somewhat lower. benzene. The plasma-levels of A4-androstenedione and The C18-steroids were rechromatographed in testosterone were almost equal. The plasma-levels formamid/chloroform, the C19-steroids in propyl- of the C19-steroids showed the same temporal englycol/cyclohexan (see KNÜPFEN [4] for further course äs those of the C18-steroids. The highest details). The resulting metabolites estrone (Oej), values were detected at 180 minutes. 16a-hydroxyestrone (loa-OH-Oej) and estradiol- (OE2-17/3) äs well äs the androgens, 4- androstenedione and testosterone were reduced or 3 Discussion oxidized, rechromatographed and characterized in The fetal adrenal cortex produces 75% of the total the following manner: DHEA-S which is then primarily C-l 6-hydroxylated *!. Oxidation by 3, 17/J-hydroxysteroid-reductase in the fetal liver. DHEA-S and 16a-OH-DHEA-S (EC 1.1.1.51) type I Sigma Chemicals, St. Louis, reach the placenta äs estrogen-precursors through USA. the umbilical arteries and are converted via 2. Reduction by sodiumboranate in methanol. androstenedione and 19-hydroxyandrostenedione to estrogens, mainly to estriol [l, 14,17,18]. For Estriol (Oe3), DHEA and 16a-OH-DHEA were this conversion the placenta is provided with the partially acetylated and identified by recrystal- following enzymes arylsulfatase, 3j3-hydroxy- lization to constant specific activity. steroiddehydrogenase-A4-As-isomerase, 19-hy- After localization of the metabolites by parallel- droxylase and the aromatizing enzymesystem. The running, labelled test-chromatogramms, extraction additional activity of the placental microsomal from the paper was performed with methanol and enzyme 170-hydroxysteroiddehydrogenase causes radioactivity measured in a liquid-szintillation- formation of testosterone by reduction of andro- counter. The quantity of plasma-steroids was ex- stenedione and also of estradiol-17/3 from estrone pressed in nCi/100 ml plasma. [16, 8]. In our injection study we simulated physi- ological processes described above by applying the labelled and unlabelled DHEA directly to the feto- 2 Results placental unit by intraamniotical injection. The course of the plasma-levels for each steroid- The quantity of the exogenous hormones admin- fraction during the test-period is shown in Tab. L istered in our test is within the normal physiological The values for the 4 isolated C18-steroids over the ränge. The normal fetus produces about 70 mg test-period are additionally demonstrated in graphs DHEA-S in 24 hrs.; however, we injected 5 mg (see figures). From the C18-steroids, the two C16 unlabelled DHEA and measured its metabolites hydroxylated compounds, estriol and 16-hydroxy- over a 4 hr. period. Only 5 g of labelled DHEA estrone, have been isolated. Seventy-five percent was used to enable qualitative analysis. of all originating estrogens were hydroxylated at Previous investigators have shown that prior to the C16. Estradiol-17/3 and estrone were found in 20th week of gestation the fetus sw.allows signif- approximately the same quantity. In contrast the icant volumes of amniotic fluid. The high 16 - estriol level was 2 to 3 times higher than that of hydroxylaseactivity of the fetal liver [9, 11] causes the other estrogens. The peak plasma concentration C16-hydroxylation of 75% of all recovered met- of all C18-steroids appeared 180 minutes after abolites (Tab. I): The main 16-hydroxylated met- (3H)-DHEA-S injection with the exception of abolite is 16a-OH-DHEA and after placenta- estrone which reached its maximum concentration passage 16a-OH-estrone and estriol. 15 minutes slightly earlier, that is after 120 minutes. after intraamniotic injection of DHEA-S a signif- J.Perinat. Med. 4(1976) Lehman n et aL, Intraamniolic injcction of DHBA-S in mid-prcgnancy 257 Tab. I. Level of ptaima eUrogcns (nCi/100 ml pla*ma) and of untijrogcnic precu/sors following intraamniotic injcction of 100 jjCi (JH)-dchydrocpiündroj>tcrone-sulfatc. Time (min) Oc3 Oer170 16a-OH-Oc, DHEA 16a-OH-DHEA A4-Androst. Testostcron Case l . 15 260 63 48 41 63 75 24 32 30 340 9l 100 60 78 102 48 52 60 490 130 190 70 97 120 65 67 120 520 150 200 85 100 125 79 98 180 710 262 240 100 82 140 85 100 240 640 220 203 90 60 79 43 91 Case 2 15 325 75 65 49 75 90 29 38 30 410 110 124 72 95 122 50 63 60 580 156 230 84 120 134 78 89 120 650 180 270 102 131 151 95 112 180 810 324 293 121 128 168 101 121 240 720 268 254 HO 75 96 52 99 Casc 3 15 340 100 90 51 90 121 34 44 30 430 110 130 71 102 142 52 63 60 600 170 200 85 112 154 69 74 120 675 200 250 90 140 160 85 90 180 870 305 170 105 120 187 97 80 240 750 270 100 80 82 136 66 56 Casc 4 15 240 72 81 68 75 101 28 37 30 325 89 122 79 98 112 38 49 60 456 120 154 85 110 134 49 62 120 528 172 163 108 130 158 59 78 180 690 218 134 145 122 177 85 72 240 581 154 103 110 91 127 44 41 icant quantity of labelled metabolites appears in several hours, since the elimination of steroids by the maternal circulation. As illustrated in the the kidney is rapid i.e. within 30 minutes. Twenty graphs, the plasmalevels of the metabolites in all 4 five percent of the swallowed DHEA is not C16- cases tested increased up to 3 hrs. after injection hydroxylated and therefore seems not to pass the and then decreased rather quickly. Our Inter- fetal liver and consequently to reach the placenta pretation of the results is, that the fetus continously without 16a-hydroxylation. Here it is converted swallows the amniotic fluid (approx. 300—500 ml to A4-androstenedionetestosterone and to estrone in the 20 th week fo gestation) containing the and estradiol-17/3 via the A4-metabolic pathway. dispersed radioactive steroid, metabolizes it and These fractions enter the maternal circulation and delivers it into the maternal circulation after were identified in plasma äs shown in table I. One placental passage.
Recommended publications
  • Estrone Sulfate
    Available online at www.sciencedirect.com Journal of Steroid Biochemistry & Molecular Biology 109 (2008) 158–167 Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa)ଝ Frank Giton a,∗, Alexandre de la Taille b, Yves Allory b, Herve´ Galons c, Francis Vacherot b, Pascale Soyeux b, Claude Clement´ Abbou b, Sylvain Loric b, Olivier Cussenot b, Jean-Pierre Raynaud d, Jean Fiet b a AP-HP CIB INSERM IMRB U841eq07, Henri Mondor, Facult´edeM´edecine, 94010 Cr´eteil, France b INSERM IMRB U841 eq07, CHU Henri Mondor, Facult´edeM´edecine, 94010 Cr´eteil, France c Service de Chimie organique, Facult´e de Pharmacie Paris V, 75006 Paris, France d Universit´e Pierre et Marie Curie, 75252 Paris, France Received 26 December 2006; accepted 26 October 2007 Abstract Seeking insight into the possible role of estrogens in prostate cancer (PCa) evolution, we assayed serum E2, estrone (E1), and estrone sulfate (E1S) in 349 PCa and 100 benign prostatic hyperplasia (BPH) patients, and in 208 control subjects in the same age range (50–74 years). E1 (pmol/L ± S.D.) and E1S (nmol/L ± S.D.) in the PCa and BPH patients (respectively 126.1 ± 66.1 and 2.82 ± 1.78, and 127.8 ± 56.4 and 2.78 ± 2.12) were significantly higher than in the controls (113.8 ± 47.6 and 2.11 ± 0.96). E2 was not significantly different among the PCa, BPH, and control groups. These assays were also carried out in PCa patients after partition by prognosis (PSA, Gleason score (GS), histological stage, and surgical margins (SM)).
    [Show full text]
  • Alteration of the Steroidogenesis in Boys with Autism Spectrum Disorders
    Janšáková et al. Translational Psychiatry (2020) 10:340 https://doi.org/10.1038/s41398-020-01017-8 Translational Psychiatry ARTICLE Open Access Alteration of the steroidogenesis in boys with autism spectrum disorders Katarína Janšáková 1, Martin Hill 2,DianaČelárová1,HanaCelušáková1,GabrielaRepiská1,MarieBičíková2, Ludmila Máčová2 and Daniela Ostatníková1 Abstract The etiology of autism spectrum disorders (ASD) remains unknown, but associations between prenatal hormonal changes and ASD risk were found. The consequences of these changes on the steroidogenesis during a postnatal development are not yet well known. The aim of this study was to analyze the steroid metabolic pathway in prepubertal ASD and neurotypical boys. Plasma samples were collected from 62 prepubertal ASD boys and 24 age and sex-matched controls (CTRL). Eighty-two biomarkers of steroidogenesis were detected using gas-chromatography tandem-mass spectrometry. We observed changes across the whole alternative backdoor pathway of androgens synthesis toward lower level in ASD group. Our data indicate suppressed production of pregnenolone sulfate at augmented activities of CYP17A1 and SULT2A1 and reduced HSD3B2 activity in ASD group which is partly consistent with the results reported in older children, in whom the adrenal zona reticularis significantly influences the steroid levels. Furthermore, we detected the suppressed activity of CYP7B1 enzyme readily metabolizing the precursors of sex hormones on one hand but increased anti-glucocorticoid effect of 7α-hydroxy-DHEA via competition with cortisone for HSD11B1 on the other. The multivariate model found significant correlations between behavioral indices and circulating steroids. From dependent variables, the best correlation was found for the social interaction (28.5%). Observed changes give a space for their utilization as biomarkers while reveal the etiopathogenesis of ASD.
    [Show full text]
  • The Relationship Between Serum Sex Steroid Levels and Heart Rate Variability Parameters in Males and the Effect Of
    Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2010;38(7):459-465 459 The relationship between serum sex steroid levels and heart rate variability parameters in males and the effect of age Erkeklerde serum cinsiyet steroidleri ile kalp hızı değişkenliği verileri arasındaki ilişki ve yaşın etkileri M. Tolga Doğru, M.D., M. Murad Başar, M.D.,# Ercan Yuvanç, M.D.,# Vedat Şimşek, M.D., Ömer Şahin, M.D. Departments of Cardiology and #Urology, Medicine Faculty of Kırıkkale University, Kırıkkale Objectives: We evaluated the relationships between sex Amaç: Bu çalışmada cinsiyet steroidleri ile kalp hızı de- steroid levels and heart rate variability (HRV) parameters. ğişkenliği (KHD) verileri arasındaki ilişkiler araştırıldı. Study design: The study included 114 male subjects (mean Çalışma planı: Çalışmaya, kardiyolojik açıdan değerlen- age 46.6±11.3 years) presenting to our department for cardi- dirme için başvuran 114 erkek hasta (ort. yaş 46.6±11.3) ologic evaluation. Hormonal analysis included serum levels alındı. Hormon analizlerinde serumda luteinize edici hor- of luteinizing hormone, prolactin, total testosterone (TT), free mon, prolaktin, total testosteron (TT), serbest testosteron, testosterone, estradiol (E2), and dehydroepiandrosterone östradiol (E2) ve dehidroepiandrosteron sülfat (DHEA-S) sulfate (DHEA-S). Parameters of HRV were derived from düzeyleri ölçüldü. Yirmi dört saatlik Holter kayıtlarından 24-hour Holter monitoring. The associations between serum KHD parametreleri hesaplandı. Serum cinsiyet steroidleri sex steroid levels and HRV parameters were investigated in ile KHD değerleri arasındaki ilişkiler hastalar üç yaş gru- three age groups (20-39 years; 40-59 years; >60 years). buna (20-39 yaş; 40-59 yaş; >60 yaş) ayrılarak incelendi.
    [Show full text]
  • Conjugated and Unconjugated Plasma Androgens in Normal Children
    Pediat. Res. 6: 111-118 (1972) Androstcncdionc sexual development dehydroepiandrosterone testosterone Conjugated and Unconjugated Plasma Androgens in Normal Children DONALD A. BOON,'291 RAYMOND E. KEENAN, W. ROY SLAUNWHITE, JR., AND THOMAS ACETO, JR. Children's Hospital, Medical Foundation of Buffalo, Roswell Park Memorial Institute, and Departments of Biochemistry and Pediatrics, School of Medicine, State University of New York at Buffalo, Buffalo, New York, USA Extract Methods developed in this laboratory permit measurement of the androgens, testos- terone (T), dehydroepiandrosterone (D), and androstenedione (A) on a 10-ml sample of plasma. We have determined concentrations of the unconjugated androgens (T, A, D) as well as of the sulfates of dehydroepiandrosterone (DS) and androsterone (AS) in the plasma of 85 healthy children of both sexes from birth through the age of 20 years. Our results are shown and summarized, along with those of other investigators. Mean plasma concentrations Sex and age ng/100 ml Mg/100 ml T A D AS DS Male Neonates 39 24 30 None detectable None detectable 1-8 years 25 58 64 2 11 9-20 years 231 138 237 28 74 Female Neonates 36 30 83 None detectable None detectable 1-8 years 11 69 54 5 20 9-20 years 28 84 164 22 44 Testosterone was elevated in both sexes in the newborn as compared with the 1-8- year-old group. In contrast, sulfated androgens, with one exception, were undetectable early in life. In males, there was a marked rise in all androgens, especially T, in the 9-18-year-old group.
    [Show full text]
  • Memory-Enhancing Effects in Male Mice of Pregnenolone and Steroids Metabolically Derived from It
    Proc. Nati. Acad. Sci. USA Vol. 89, pp. 1567-1571, March 1992 Neurobiology Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it (memory enhancement/pregnenolone sulfate/receptors/immediate-early genes/aging) JAMES F. FLOOD*t, JOHN E. MORLEY*, AND EUGENE ROBERTSt§ *Genatnc Research Education and Clinical Center, Veterans Administration Medical Center, St. Louis, MO 63106, and St. Louis University School of Medicine, Division of Geriatric Medicine, St. Louis, MO 63104; and tDepartment of Neurobiochemistry, Beckman Research Institute of the City of Hope, Duarte, CA 91010 Contributed by Eugene Roberts, November 8, 1991 ABSTRACT Immediate post-training intracerebroven- postmitotic differentiated states was favored in both neurons tricular administration to male mice of pregnenolone (P), and glia (7, 8). pregnenolone sulfate (PS), dehydroepiandrosterone (DHEA), The water-soluble DHEAS, administered intracerebro- dehydroepiandrosterone sulfate (DHEAS), androstenedione, ventricularly (i.c.v.) or subcutaneously (s.c.) after training, testosterone, dihydrotestosterone, or aldosterone caused im- showed convincing memory-enhancing (ME) effects in foot- provement ofretention for footshock active avoidance training, shock active avoidance training (FAAT) in undertrained male while estrone, estradiol, progesterone, or 16.8-bromoepi- mice. DHEAS administered i.c.v. facilitated retention for androsterone did not. Dose-response curves were obtained for step-down passive avoidance training. Retention of FAAT P, PS, DHEA, and testosterone. P and PS were the most potent, was improved when DHEAS was given in taste-camouflaged PS showing significant effects at 3.5 fmol per mouse. The active drinking water for 1 week before and 1 week after training, steroids did not show discernible structural features or known while DHEAS in the drinking water for 2 weeks did not membrane or biochemical effects that correlated with their improve acquisition (9).
    [Show full text]
  • Steroid Secretion. Newly Discovered Functions in the Brain
    Steroid secretion. Newly Discovered Functions in the Brain. Fundamental and Clinical considerations. Bernardo O. Dubrovsky McGill University Medical School Montreal, Quebec, Canada B.O. Dubrovsky, 3445 Drummond Street, #701, Montreal, Quebec, H3G 1X9,Canada. Tel: (514) 844-5702 Fax: (514) 398-4370 E-mail: [email protected] Abstract While the relationships between endocrines and psychiatry have long been established, the implications of neurosteroid (NS) hormones, identified in the early 1980s for psychopathology, started to be recognized in the nineties. Tetrahydro metabolites of progesterone (ATHP) and deoxycorticosterone (ATHDOC) act as positive allosteric modulators of neurotransmitter receptors such as GABAA. Other NSs, i.e., androsterone, pregnenolone, dehydroepiandrosterone (DHEA), their sulfates and lipid derivatives modulate glycine-activated chloride channels, neural nicotinic acetylcholine receptors constituted in Xenopus laevis oocytes, and voltage-activated calcium channels. Sigma receptors, as pharmacologically defined by their effect on N-methyl-D- aspartate (NMDA) activity, have been studied in rat hippocampal preparations: here DHEAS acts as a sigma receptor agonist, differently from pregnenolone which appears as a sigma inverse agonist and progesterone which behaves as an antagonist. All of them were identified as NSs. Neuroactive steroids rapidly change CNS excitability and produce behavioral effects within seconds to minutes following administration to both laboratory animals and man. These fast actions probably indicate membrane mediated effects. This notwithstanding, Rupprecht et al. showed that after oxidation, ring A reduced pregnanes can regulate gene expression via the progesterone intracellular receptor. The necessary enzymes for the metabolism of primary adrenal and gonadal steroids, a peripheral source for NSs, exist in the brain in a compartmentalized way.
    [Show full text]
  • Memory-Enhancing Effects in Male Mice of Pregnenolone and Steroids
    Proc. Nati. Acad. Sci. USA Vol. 89, pp. 1567-1571, March 1992 Neurobiology Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it (memory enhancement/pregnenolone sulfate/receptors/immediate-early genes/aging) JAMES F. FLOOD*t, JOHN E. MORLEY*, AND EUGENE ROBERTSt§ *Genatnc Research Education and Clinical Center, Veterans Administration Medical Center, St. Louis, MO 63106, and St. Louis University School of Medicine, Division of Geriatric Medicine, St. Louis, MO 63104; and tDepartment of Neurobiochemistry, Beckman Research Institute of the City of Hope, Duarte, CA 91010 Contributed by Eugene Roberts, November 8, 1991 ABSTRACT Immediate post-training intracerebroven- postmitotic differentiated states was favored in both neurons tricular administration to male mice of pregnenolone (P), and glia (7, 8). pregnenolone sulfate (PS), dehydroepiandrosterone (DHEA), The water-soluble DHEAS, administered intracerebro- dehydroepiandrosterone sulfate (DHEAS), androstenedione, ventricularly (i.c.v.) or subcutaneously (s.c.) after training, testosterone, dihydrotestosterone, or aldosterone caused im- showed convincing memory-enhancing (ME) effects in foot- provement ofretention for footshock active avoidance training, shock active avoidance training (FAAT) in undertrained male while estrone, estradiol, progesterone, or 16.8-bromoepi- mice. DHEAS administered i.c.v. facilitated retention for androsterone did not. Dose-response curves were obtained for step-down passive avoidance training. Retention of FAAT P, PS, DHEA, and testosterone. P and PS were the most potent, was improved when DHEAS was given in taste-camouflaged PS showing significant effects at 3.5 fmol per mouse. The active drinking water for 1 week before and 1 week after training, steroids did not show discernible structural features or known while DHEAS in the drinking water for 2 weeks did not membrane or biochemical effects that correlated with their improve acquisition (9).
    [Show full text]
  • A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer
    Published OnlineFirst February 7, 2019; DOI: 10.1158/1055-9965.EPI-18-1002 Research Article Cancer Epidemiology, Biomarkers A Comprehensive Analysis of Steroid Hormones & Prevention and Progression of Localized High-Risk Prostate Cancer Eric Levesque 1, Patrick Caron2, Louis Lacombe1,Veronique Turcotte2, David Simonyan3, Yves Fradet1, Armen Aprikian4, Fred Saad5, Michel Carmel6, Simone Chevalier4, and Chantal Guillemette2 Abstract Background: In men with localized prostate cancer who are terone levels were higher in low-risk disease. Associations were undergoing radical prostatectomy (RP), it is uncertain whether observed between adrenal precursors and risk of cancer pro- their systemic hormonal environment is associated with out- gression. In high-risk patients, a one-unit increment in log- comes. The objective of the study was to examine the associ- transformed androstenediol (A5diol) and dehydroepiandros- ation between the circulating steroid metabolome with prog- terone-sulfate (DHEA-S) levels were linked to DFS with HR of nostic factors and progression. 1.47 (P ¼ 0.0017; q ¼ 0.026) and 1.24 (P ¼ 0.043; q ¼ 0.323), Methods: The prospective PROCURE cohort was recruited respectively. Although the number of metastatic events was from 2007 to 2012, and comprises 1,766 patients with local- limited, trends with metastasis-free survival were observed for ized prostate cancer who provided blood samples prior to RP. A5diol (HR ¼ 1.51; P ¼ 0.057) and DHEA-S levels (HR ¼ 1.43; The levels of 15 steroids were measured in plasma using mass P ¼ 0.054). spectrometry, and their association with prognostic factors and Conclusions: In men with localized prostate cancer, our disease-free survival (DFS) was established with logistic regres- data suggest that the preoperative steroid metabolome is sion and multivariable Cox proportional hazard models.
    [Show full text]
  • Relationships of Dehydroepiandrosterone Sulfate In
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 13410–13415, November 1996 Population Biology Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study CLAUDINE BERR*, SYLVIANE LAFONT†,BRIGITTE DEBUIRE‡,JEAN-FRANC¸OIS DARTIGUES†, AND ETIENNE-EMILE BAULIEU§¶ *Institut National de la Sante´et de la Recherche Me´dicaleU360, Recherches Epide´miologiques en Neurologie et Psychopathologie, Hoˆpital de la Salpe´trie`re, 75651 Paris Cedex 13, France; †Institut National de la Sante´et de la Recherche Me´dicaleU330, Epide´miologie,Sante´Publique et De´veloppement,Universite´ Bordeaux II, 33076 Bordeaux Cedex, France; ‡Service de Biochimie, Hoˆpital Paul Brousse, 94808 Villejuif Cedex, France; and §Institut National de la Sante´ et de la Recherche Me´dicaleU33, Communications Hormonales, Hoˆpital de Biceˆtre,94276 Le Kremlin-BiceˆtreCedex, France Contributed by Etienne-Emile Baulieu, August 28, 1996 ABSTRACT In human beings of both sexes, dehydroepi- DHEA (also secreted by the adrenals), which itself can be androsterone sulfate (DHEAS) circulating in blood is mostly partially metabolized into active androgens and estrogens in an adrenally secreted steroid whose serum concentration (in peripheral tissues (1–5). However, the physiological signifi- the micromolar range and 30–50% higher in men than in cance of this conversion to potent sex hormones is still not women) decreases with age, toward '20–10% of its value in understood, even though it
    [Show full text]
  • Impaired Glucocorticoid Synthesis in Premature Infants Developing Chronic Lung Disease
    0031-3998/01/5002-0190 PEDIATRIC RESEARCH Vol. 50, No. 2, 2001 Copyright © 2001 International Pediatric Research Foundation, Inc. Printed in U.S.A. Impaired Glucocorticoid Synthesis in Premature Infants Developing Chronic Lung Disease KRISTI L. WATTERBERG, JEFFREY S. GERDES, AND KRISTEN L. COOK Department of Pediatrics, University of New Mexico, Albuquerque, NM, U.S.A. [K.L.W.]; the Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, U.S.A. [J.S.G.]; and the Department of Pediatrics, Pennsylvania State University, Hershey, PA, U.S.A. [K.L.C.] ABSTRACT Premature infants have higher cortisol precursor concentra- were lower in CLD infants. In contrast, the basal ratio of tions than term infants; however, many sick preterm infants have 11-deoxycortisol to cortisol was higher in CLD infants, as were surprisingly low cortisol concentrations. Those who develop stimulated values of 17-OH progesterone and stimulated ratios of chronic lung disease (CLD) have lower cortisol values than those 17-OH progesterone to 11-deoxycortisol and 11-deoxycortisol to who recover. We hypothesized that some infants have a de- cortisol. Thus, infants who developed CLD had lower basal and creased ability to synthesize cortisol, leading to physiologic stimulated cortisol values, but elevated cortisol precursors and disruptions including amplified inflammatory responses, thereby precursor to product ratios, compared with infants who recov- resulting in CLD. We measured cortisol, 11-deoxycortisol, 17- ered. These data support the hypothesis that these immature hydroxyprogesterone, 17-hydroxypregnenolone, dehydroepi- infants have a decreased capacity to synthesize cortisol, which androsterone sulfate, and ACTH in 40 extremely low birth may lead to a relative adrenal insufficiency in the face of weight infants enrolled in a study of low-dose hydrocortisone significant illness.
    [Show full text]
  • Part A. Serum Androgen Levels in Women Aged 20–49 Years with No Complaints of Sexual Dysfunction
    International Journal of Impotence Research (2004) 16, 112–120 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $25.00 www.nature.com/ijir Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20–49 years with no complaints of sexual dysfunction A Guay1*, R Munarriz2, J Jacobson1, L Talakoub2, A Traish2, F Quirk3, I Goldstein2 and R Spark4 1Center for Sexual Function, Lahey Clinic, Peabody, Massachusetts, USA; 2Institute for Sexual Medicine, Boston University School of Medicine, Boston, Massachusetts, USA; 3Central Research, Pfizer Ltd., Sandwich, UK; and 4Steroid Research Laboratory, Beth Israel-Deaconess Medical Center, Boston, Massachusetts, USA Androgen insufficiency is a recognized cause of sexual dysfunction in men and women. Age-related decrements in adrenal and gonadal androgen levels also occur naturally in both sexes. At present, it is unclear if a woman’s low serum androgen level is a reflection of the expected normal age-related decline or indicative of an underlying androgen-deficient state. We studied premenopausal women with no complaints of sexual dysfunction to help define a normal female androgen profile. In all, 60 healthy, normally menstruating women, ages 20–49 y, were studied. The Abbreviated Sexual Function Questionnaire was administered along with a detailed interview. Radioimmunoassay measurements of morning serum testosterone (T), free testosterone (fT), dehydroepiandrosterone- sulfate (DHEAS), sex hormone-binding globulin (SHBG), and free androgen index (FAI) were measured during days 8–15 of the menstrual cycle. In women 20–49 y old without complaints of sexual dysfunction, serum androgen levels exhibit a progressive stepwise decline.
    [Show full text]
  • Steroid Hormone Accumulation in Human Breast Cyst Fluid1
    [CANCER RESEARCH 41, 105-107. January 1981] 0008-5472/81 /0041-OOOOS02.00 Steroid Hormone Accumulation in Human Breast Cyst Fluid1 H. Leon Bradlow,2 Robert S. Rosenfeld, Jacob Kream, Martin Fleisher, John O'Connor, and Morton K. Schwartz The Rockefeller University [H L B ] and Memorial Sloan Kettering Cancer Center. New York. New York 10021 [M. F.. M. K. S.], and Institute for Steroid Research. Montefiore Hospital and Medical Center. Bronx. New York 10467 [R. S P., J. K.. J. O.} ABSTRACT MATERIALS AND METHODS Elevated concentrations of peptide hormones have been described previously in human breast fluid. In the current study, Cyst fluid was obtained from patients as they presented to the levels of cortisol, progesterone, testosterone, dihydrotes- their physician for treatment, at which time simultaneous blood tosterone, androsterone, androsterone sulfate, dehydroisoan- samples were collected. Plasma and cyst fluid were frozen at drosterone, dehydroisoandrosterone sulfate, estradiol, es —20°until they were assayed. The samples were analyzed by trone, estradici sulfate, and estrone sulfate were measured. RIA3 procedures originally devised for the analysis of plasma. The levels of the four 17-ketosteroids and the two estrogen Because the assays of these compounds involve solvent ex sulfates were markedly elevated over the plasma level, while traction and column chromatography prior to RIA, no problems that of the other compounds was the same or only slightly in applying this method to the analysis of cyst fluid samples higher than the plasma levels of the same compounds. were anticipated. Nevertheless, applicability of these proce dures to the analysis of steroids in cyst fluids was validated by INTRODUCTION serial dilution and by recovery studies in which known amounts of steroids were added to aliquots of cyst fluids.
    [Show full text]